Erlotinib for whole-brain-radiotherapy-refractory leptomeningeal metastases after gefitinib failure in a lung adenocarcinoma patient

Journal of Thoracic Oncology

Volumn 7, Issue 4, 2012, Pages 770-771

  Hata, Akito ^a   Katakami, Nobuyuki ^a   Kaji, Reiko ^a   Fujita, Shiro ^a   Imai, Yukihiro ^a  

^a INSTITUTE OF BIOMEDICAL RESEARCH AND INNOVATION   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; ERLOTINIB; GEFITINIB;

AGED; BRAIN METASTASIS; CANCER RADIOTHERAPY; CASE REPORT; CEREBROSPINAL FLUID CYTOLOGY; COMPUTER ASSISTED TOMOGRAPHY; CYTODIAGNOSIS; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FEMALE; HUMAN; HUMAN TISSUE; LEPTOMENINGEAL METASTASIS; LETTER; LUNG ADENOCARCINOMA; LUNG METASTASIS; MUTATIONAL ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PERICARDIAL EFFUSION; PLEURA EFFUSION; POINT MUTATION; PRIORITY JOURNAL; TREATMENT OUTCOME; TREATMENT RESPONSE; WHOLE BRAIN RADIOTHERAPY;

EID: 84858776340     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e31824c96bc     Document Type: Letter

References (5)

1. Morris PG, Reiner AS, Szenberg OR, et al. Leptomeningeal Metastasis from Non-small Cell Lung Cancer: Survival and the Impact of Whole Brain Radiotherapy. J Thorac Oncol 2012;7:382-385.
2. Lee YJ, Choi HJ, Kim SK, et al. Frequent central nervous system failure after clinical benefit with epidermal growth factor receptor tyrosine kinase inhibitors in Korean patients with nonsmall-cell lung cancer. Cancer 2010;116:1336-1343.
3. Shingyoji M, Kageyama H, Sakaida T, et al. Detection of epithelial growth factor receptor mutations in cerebrospinal fluid from patients with lung adenocarcinoma suspected of neoplastic meningitis. J Thorac Oncol 2011;6:1215-1220.
4. Katayama T, Shimizu J, Suda K, et al. Efficacy of erlotinib for brain and leptomeningeal metastases in patients with lung adenocarcinoma who showed initial good response to gefitinib. J Thorac Oncol 2009;4:1415-1419.
5. Jackman D, Pao W, Riely GJ, et al. Clinical definition of acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer. J Clin Oncol 2010;28:357-360.